Related Experiment Video
Updated: Aug 8, 2026

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
Published on: June 25, 2014
Introduction to the background, principles, and state of the art in suicide gene therapy
Ion Niculescu-Duvaz1, Caroline J Springer
1Cancer Research, UK Centre for Cancer Therapeutics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK.
Abstract:
Gene therapy is defined as a technology that aims to modify the genetic component of cells to gain therapeutic benefits. Suicide gene therapy (or gene-directed enzyme prodrug therapy [GDEPT]) is a two-step treatment for cancer (especially, solid tumors). In the first step, a gene for a foreign enzyme is delivered to the tumor by a vector. Following the expression of the foreign enzyme, a prodrug is administered during the second step, which is selectively activated in the tumor. This article discusses the principles and the theorectical background of GDEPT. A special emphasis is put on enzyme/prodrug systems developed for GDEPT, the design of prodrugs and the kinetic of their activation, the types and the mechanisms of bystander effect and its immunological implications. The possible strategies to improve GDEPT are also discussed.
Insights
Suicide gene therapy, or gene-directed enzyme prodrug therapy (GDEPT), uses a two-step approach to treat solid tumors. It involves delivering a foreign enzyme gene to the tumor, followed by administering a prodrug that is activated by the enzyme.
Area of Science:
- Oncology
- Gene Therapy
- Pharmacology
Background:
- Gene therapy modifies cellular genetic components for therapeutic effects.
- Suicide gene therapy (GDEPT) is a two-step cancer treatment, particularly for solid tumors.
- It utilizes a foreign enzyme delivered to the tumor, which activates a subsequently administered prodrug.
Purpose of the Study:
- To discuss the principles and theoretical background of gene-directed enzyme prodrug therapy (GDEPT).
- To emphasize enzyme/prodrug systems, prodrug design, and activation kinetics in GDEPT.
- To explore bystander effect mechanisms, immunological implications, and strategies for improving GDEPT.
Main Methods:
- Delivery of a foreign enzyme gene to tumor cells via a vector.
- Administration of a specific prodrug in the second treatment step.
- Selective activation of the prodrug within the tumor microenvironment.
Main Results:
- Detailed discussion of GDEPT principles and theoretical underpinnings.
- Analysis of various enzyme/prodrug systems and prodrug design strategies.
- Exploration of bystander effects, their mechanisms, immunological impact, and optimization strategies.
Conclusions:
- GDEPT offers a targeted approach to cancer treatment by exploiting enzyme-prodrug interactions.
- Understanding prodrug activation, bystander effects, and immunological responses is crucial for GDEPT efficacy.
- Further research into improving GDEPT strategies holds promise for enhanced cancer therapy.
Related Concept Videos
What is Genetic Engineering?
In-vitro Mutagenesis
Gene Therapy
Gene Therapy
Introduction to Nuclear Reprogramming
Microorganisms in Medicine and Therapeutics

